Switch to:
Also traded in: UK
» Details

Insider Trades

Latest Guru Trades with CSRMY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112 
Compare:NAS:OFIX, NYSE:CRY, NAS:GNMK, NAS:ARAY, OTCPK:MZRTF, NAS:KTWO, NYSE:IVC, NAS:XENT, NAS:MDXG, NAS:AXGN, NAS:EXAC, NAS:ELOS, NAS:CSII, NAS:VASC, OTCPK:NMRD, NAS:CUTR, NAS:TCMD, NAS:VRAY, OTCPK:IPDQF, NAS:RTIX » details
Traded in other countries:CSRT.UK,
Consort Medical PLC is engaged in designing, development and manufacturing of specialty medical drug delivery devices and services to the pharmaceutical industry.

Consort Medical PLC was incorporated on March 22, 1946. The Company is engaged in the designing, development and manufacturing of specialty medical drug delivery devices and services to the pharmaceutical industry through Bespak and the supply of active pharmaceutical ingredient and finished dose formulation and manufacturing services through Aesica. Its products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Ratios

vs
industry
vs
history
P/E(ttm) 26.79
CSRMY's P/E(ttm) is ranked lower than
51% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.50 vs. CSRMY: 26.79 )
Ranked among companies with meaningful P/E(ttm) only.
CSRMY' s P/E(ttm) Range Over the Past 10 Years
Min: 8.02  Med: 15.01 Max: 96.25
Current: 26.79
8.02
96.25
Forward P/E 16.00
CSRMY's Forward P/E is ranked higher than
87% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 23.92 vs. CSRMY: 16.00 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.45
CSRMY's PE(NRI) is ranked higher than
51% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 25.48 vs. CSRMY: 25.45 )
Ranked among companies with meaningful PE(NRI) only.
CSRMY' s PE(NRI) Range Over the Past 10 Years
Min: 11.06  Med: 16.59 Max: 76.49
Current: 25.45
11.06
76.49
Price/Owner Earnings (ttm) 18.58
CSRMY's Price/Owner Earnings (ttm) is ranked higher than
71% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 30.29 vs. CSRMY: 18.58 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
CSRMY' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.19  Med: 16.03 Max: 1050
Current: 18.58
6.19
1050
P/B 2.37
CSRMY's P/B is ranked higher than
61% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. CSRMY: 2.37 )
Ranked among companies with meaningful P/B only.
CSRMY' s P/B Range Over the Past 10 Years
Min: 1.27  Med: 2.28 Max: 3.47
Current: 2.37
1.27
3.47
P/S 1.82
CSRMY's P/S is ranked higher than
67% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 3.29 vs. CSRMY: 1.82 )
Ranked among companies with meaningful P/S only.
CSRMY' s P/S Range Over the Past 10 Years
Min: 0.65  Med: 1.7 Max: 3.03
Current: 1.82
0.65
3.03
PFCF 31.61
CSRMY's PFCF is ranked lower than
58% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. CSRMY: 31.61 )
Ranked among companies with meaningful PFCF only.
CSRMY' s PFCF Range Over the Past 10 Years
Min: 7.35  Med: 20.08 Max: 38
Current: 31.61
7.35
38
POCF 13.45
CSRMY's POCF is ranked higher than
69% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 18.12 vs. CSRMY: 13.45 )
Ranked among companies with meaningful POCF only.
CSRMY' s POCF Range Over the Past 10 Years
Min: 4.71  Med: 10.47 Max: 54.24
Current: 13.45
4.71
54.24
EV-to-EBIT 41.71
CSRMY's EV-to-EBIT is ranked lower than
74% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.48 vs. CSRMY: 41.71 )
Ranked among companies with meaningful EV-to-EBIT only.
CSRMY' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.7  Med: 12.5 Max: 76.1
Current: 41.71
7.7
76.1
EV-to-EBITDA 15.85
CSRMY's EV-to-EBITDA is ranked higher than
51% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 15.79 vs. CSRMY: 15.85 )
Ranked among companies with meaningful EV-to-EBITDA only.
CSRMY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.7  Med: 8 Max: 25.6
Current: 15.85
4.7
25.6
Shiller P/E 28.17
CSRMY's Shiller P/E is ranked higher than
80% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 49.62 vs. CSRMY: 28.17 )
Ranked among companies with meaningful Shiller P/E only.
CSRMY' s Shiller P/E Range Over the Past 10 Years
Min: 10.41  Med: 22.35 Max: 39.28
Current: 28.17
10.41
39.28
Current Ratio 0.65
CSRMY's Current Ratio is ranked lower than
93% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. CSRMY: 0.65 )
Ranked among companies with meaningful Current Ratio only.
CSRMY' s Current Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.32 Max: 3.58
Current: 0.65
0.55
3.58
Quick Ratio 0.46
CSRMY's Quick Ratio is ranked lower than
94% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. CSRMY: 0.46 )
Ranked among companies with meaningful Quick Ratio only.
CSRMY' s Quick Ratio Range Over the Past 10 Years
Min: 0.38  Med: 0.92 Max: 3.01
Current: 0.46
0.38
3.01
Days Inventory 162.92
CSRMY's Days Inventory is ranked lower than
62% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 130.88 vs. CSRMY: 162.92 )
Ranked among companies with meaningful Days Inventory only.
CSRMY' s Days Inventory Range Over the Past 10 Years
Min: 162.92  Med: 164.13 Max: 212.47
Current: 162.92
162.92
212.47
Days Sales Outstanding 79.64
CSRMY's Days Sales Outstanding is ranked lower than
61% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 66.78 vs. CSRMY: 79.64 )
Ranked among companies with meaningful Days Sales Outstanding only.
CSRMY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.49  Med: 43.82 Max: 118.75
Current: 79.64
37.49
118.75

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.86
CSRMY's Dividend Yield is ranked higher than
61% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 1.74 vs. CSRMY: 1.86 )
Ranked among companies with meaningful Dividend Yield only.
CSRMY' s Dividend Yield Range Over the Past 10 Years
Min: 1.57  Med: 3 Max: 5.74
Current: 1.86
1.57
5.74
Dividend Payout 0.46
CSRMY's Dividend Payout is ranked lower than
56% of the 116 Companies
in the Global Medical Devices industry.

( Industry Median: 0.41 vs. CSRMY: 0.46 )
Ranked among companies with meaningful Dividend Payout only.
CSRMY' s Dividend Payout Range Over the Past 10 Years
Min: 0.42  Med: 0.53 Max: 1.84
Current: 0.46
0.42
1.84
Dividend Growth (3y) 0.90
CSRMY's Dividend Growth (3y) is ranked lower than
72% of the 75 Companies
in the Global Medical Devices industry.

( Industry Median: 9.10 vs. CSRMY: 0.90 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CSRMY' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -0.9  Med: 1.4 Max: 19.3
Current: 0.9
-0.9
19.3
Forward Dividend Yield 1.36
CSRMY's Forward Dividend Yield is ranked lower than
63% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 1.74 vs. CSRMY: 1.36 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.92
CSRMY's Yield on cost (5-Year) is ranked higher than
52% of the 225 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. CSRMY: 1.92 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CSRMY' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.62  Med: 3.09 Max: 5.91
Current: 1.92
1.62
5.91
3-Year Average Share Buyback Ratio -13.80
CSRMY's 3-Year Average Share Buyback Ratio is ranked lower than
73% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. CSRMY: -13.80 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CSRMY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.9  Med: -0.6 Max: -0.1
Current: -13.8
-13.9
-0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 35.89
CSRMY's Price/Tangible Book is ranked lower than
95% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 4.24 vs. CSRMY: 35.89 )
Ranked among companies with meaningful Price/Tangible Book only.
CSRMY' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.25  Med: 6.97 Max: 75.2
Current: 35.89
1.25
75.2
Price/Projected FCF 2.44
CSRMY's Price/Projected FCF is ranked lower than
99.99% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 2.11 vs. CSRMY: 2.44 )
Ranked among companies with meaningful Price/Projected FCF only.
CSRMY' s Price/Projected FCF Range Over the Past 10 Years
Min: 0  Med: 1.78 Max: 3.39
Current: 2.44
0
3.39
Price/Median PS Value 1.07
CSRMY's Price/Median PS Value is ranked lower than
99.99% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 0.99 vs. CSRMY: 1.07 )
Ranked among companies with meaningful Price/Median PS Value only.
CSRMY' s Price/Median PS Value Range Over the Past 10 Years
Min: 0  Med: 0.91 Max: 1.53
Current: 1.07
0
1.53
Price/Graham Number 6.43
CSRMY's Price/Graham Number is ranked lower than
88% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. CSRMY: 6.43 )
Ranked among companies with meaningful Price/Graham Number only.
CSRMY' s Price/Graham Number Range Over the Past 10 Years
Min: 1.34  Med: 2.41 Max: 20.77
Current: 6.43
1.34
20.77
Earnings Yield (Greenblatt) (%) 2.40
CSRMY's Earnings Yield (Greenblatt) (%) is ranked higher than
63% of the 337 Companies
in the Global Medical Devices industry.

( Industry Median: -0.30 vs. CSRMY: 2.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CSRMY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.3  Med: 8 Max: 13
Current: 2.4
1.3
13
Forward Rate of Return (Yacktman) (%) -4.52
CSRMY's Forward Rate of Return (Yacktman) (%) is ranked lower than
80% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 8.88 vs. CSRMY: -4.52 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CSRMY' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -4.7  Med: 8.6 Max: 14.3
Current: -4.52
-4.7
14.3

More Statistics

Revenue (TTM) (Mil) $381.2
EPS (TTM) $ 0.51
Beta0.07
Short Percentage of Float0.00%
52-Week Range $12.90 - 15.00
Shares Outstanding (Mil)49.21

Analyst Estimate

Apr17 Apr18 Apr19
Revenue (Mil $) 365 381 402
EPS ($) 0.73 0.78 0.87
EPS w/o NRI ($) 0.73 0.78 0.87
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 0.25 0.26 0.27
» More Articles for CSRMY

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Voke® (DEV200) update Jan 04 2017
Consort Medical Plc : One of the better choices within its peer group Jan 03 2017
[$$] British American Tobacco Ends Sole Supply Deal for Nicotine Inhaler Jan 03 2017
Holding(s) in Company Dec 16 2016
Directorate Change Dec 15 2016
Holding(s) in Company Dec 15 2016
Consort Medical Plc :CSRMY-US: Earnings Analysis: For the six months ended October 31, 2016 :... Dec 09 2016
Director/PDMR Shareholding Nov 09 2016
Total Voting Rights Nov 02 2016
Notice of Results Oct 31 2016
Director/PDMR Shareholding Oct 31 2016
CIMZIA® AutoClicks® prefilled pen launched in UK Oct 28 2016
Block listing Interim Review Oct 15 2016
Announcement of master development agreement Oct 15 2016
Director/PDMR Shareholding Oct 12 2016
Consort Medical Plc : Undervalued relative to peers, but don’t ignore the other factors Oct 05 2016
Total Voting Rights Oct 04 2016
Bespak Technology in UCB PrefilledPen EMA Approval Sep 20 2016
Director/PDMR Shareholding Sep 10 2016
Result of AGM Sep 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK